Literature DB >> 34224050

A Novel Role of Nogo Proteins: Regulating Macrophages in Inflammatory Disease.

Ni Zhang1, Yuanyuan Cui1, Yuan Li1, Yajing Mi2.   

Abstract

Nogo proteins, also known as Reticulon-4, have been identified as myelin-derived inhibitors of neurite outgrowth in the central nervous system (CNS). There are three Nogo variants, Nogo-A, Nogo-B and Nogo-C. Recent studies have shown that Nogo-A/B is abundant in macrophages and may have a wider effect on inflammation. In this review, we focus mainly on the possible roles of Nogo-A/B on polarization and recruitment of macrophages and their involvement in a variety of inflammatory diseases. We then discuss the Nogo receptor1 (NgR1), a common receptor for Nogo proteins that is also abundant in microglia/macrophage in the CNS. Interaction of Nogo and NgR1 in microglia/macrophage may affect the adhesion and polarization of macrophages that are involved in multiple neurodegenerative diseases, including Alzheimer's disease and multiple sclerosis. Overall, this review provides insights into the roles of Nogo proteins in regulating macrophage functions and suggests that, potentially, Nogo proteins maybe a new target in the treatment of inflammatory diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Inflammation; Macrophages; Nogo proteins; Nogo receptor1 (NgR1)

Mesh:

Substances:

Year:  2021        PMID: 34224050     DOI: 10.1007/s10571-021-01124-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  86 in total

1.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 2.  The Involvement of the Myelin-Associated Inhibitors and Their Receptors in CNS Plasticity and Injury.

Authors:  Anthony G Boghdadi; Leon Teo; James A Bourne
Journal:  Mol Neurobiol       Date:  2017-02-22       Impact factor: 5.590

3.  Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Authors:  Diego Cadavid; Michelle Mellion; Raymond Hupperts; Keith R Edwards; Peter A Calabresi; Jelena Drulović; Gavin Giovannoni; Hans-Peter Hartung; Douglas L Arnold; Elizabeth Fisher; Richard Rudick; Sha Mi; Yi Chai; Jie Li; Yiwei Zhang; Wenting Cheng; Lei Xu; Bing Zhu; Susan M Green; Ih Chang; Aaron Deykin; Sarah I Sheikh
Journal:  Lancet Neurol       Date:  2019-07-05       Impact factor: 44.182

4.  Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model.

Authors:  Roya Aryanpour; Parichehr Pasbakhsh; Kazem Zibara; Zeinab Namjoo; Fatemeh Beigi Boroujeni; Saeed Shahbeigi; Iraj Ragerdi Kashani; Cordian Beyer; Adib Zendehdel
Journal:  Int Immunopharmacol       Date:  2017-08-19       Impact factor: 4.932

5.  Murine macrophage chemokine receptor CCR2 plays a crucial role in macrophage recruitment and regulated inflammation in wound healing.

Authors:  Anna E Boniakowski; Andrew S Kimball; Amrita Joshi; Matt Schaller; Frank M Davis; Aaron denDekker; Andrea T Obi; Bethany B Moore; Steve L Kunkel; Katherine A Gallagher
Journal:  Eur J Immunol       Date:  2018-06-26       Impact factor: 5.532

6.  PirB is a functional receptor for myelin inhibitors of axonal regeneration.

Authors:  Jasvinder K Atwal; Julie Pinkston-Gosse; Josh Syken; Scott Stawicki; Yan Wu; Carla Shatz; Marc Tessier-Lavigne
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

Review 7.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

8.  Characterization of Inflammation in Delayed Cortical Transplantation.

Authors:  Nissrine Ballout; Tristan Rochelle; Sebastien Brot; Marie-Laure Bonnet; Maureen Francheteau; Laetitia Prestoz; Kazem Zibara; Afsaneh Gaillard
Journal:  Front Mol Neurosci       Date:  2019-06-25       Impact factor: 5.639

Review 9.  Macrophages: Their role, activation and polarization in pulmonary diseases.

Authors:  Shweta Arora; Kapil Dev; Beamon Agarwal; Pragnya Das; Mansoor Ali Syed
Journal:  Immunobiology       Date:  2017-11-12       Impact factor: 3.144

10.  Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression.

Authors:  Amani A Alrehaili; Jae Young Lee; Maha M Bakhuraysah; Min Joung Kim; Pei-Mun Aui; Kylie A Magee; Steven Petratos
Journal:  Neural Regen Res       Date:  2018-05       Impact factor: 5.135

View more
  4 in total

1.  Nogo-A Is a Potential Prognostic Marker for Spinal Cord Injury.

Authors:  Haojun Shi; Liangyu Xie; Wenchang Xu; Shengnan Cao; Yuanzhen Chen
Journal:  Dis Markers       Date:  2022-05-04       Impact factor: 3.464

2.  Monomeric CRP Aggravates Myocardial Injury After Myocardial Infarction by Polarizing the Macrophage to Pro-Inflammatory Phenotype Through JNK Signaling Pathway.

Authors:  Zhimin Zha; Yujia Cheng; Lu Cao; Yanxia Qian; Xinjian Liu; Yan Guo; Junhong Wang
Journal:  J Inflamm Res       Date:  2021-12-18

3.  Anti-NOGO Antibody Neuroprotection in a Rat Model of NAION.

Authors:  Mary A Johnson; Zara Mehrabian; Yan Guo; Joy Ghosh; Mitchell G Brigell; Steven L Bernstein
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

4.  Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis.

Authors:  Agnieszka Kulczyńska-Przybik; Maciej Dulewicz; Julia Doroszkiewicz; Renata Borawska; Ala Litman-Zawadzka; Daria Arslan; Alina Kułakowska; Jan Kochanowicz; Barbara Mroczko
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.